Evoke Pharma Inc. (EVOK) Under Corrections Following FDA Market Exclusivity News Boom
On April 26, the specialty pharmaceutical company, Evoke Pharma Inc. (EVOK) rallied by over 118% mid-day. Owing to the news of FDA market exclusivity granted to the company for GIMOTI®, the stock had investors flocking towards it. Thus, at a super active volume of 215.11 million shares, EVOK surged up to a price of $1.40 […]
Evoke Pharma Inc. (EVOK) Under Corrections Following FDA Market Exclusivity News Boom Read More »